LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Precivia®* simplifies intravitreal injections by making the procedure faster and more predictable. Its unique design presents a guide tube accurately oriented to ensure a fixed injection angle of 28°, a fixed distance at 3.5 mm from the limbus, and a controlled depth.

EZYPOR® is FCI ultimate high density polyethylene orbital implant with a patented innovative suturing platform, indicated for enucleation, evisceration and secondary implantation. EZYPOR® has a smooth anterior suturing surface with 8 suture tunnels allowing multiple suturing options.

Ritleng®+ is FCI latest autostable bicanalicular nasolacrimal intubation consisting of a silicone tube connected at each extremity to a PEEK thread guide to reduce operating time and trauma for the patients. The intubation is self-retaining thanks to two wider silicone portions on the silicone tube. The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments.

EZYPOR® is FCI ultimate high density polyethylene orbital implant indicated for enucleation, evisceration and secondary implantation. EZYPOR® comes with a unique and patented smooth anterior suturing platform with 8 suture tunnels, allowing for multiple suturing options.